Background: Evidence shows cytokine dysregulation in children with developmental
| INTRODUC TI ON
Children with developmental disabilities such as autism spectrum disorder (ASD) have elevated levels of cytokines such as interleukin (IL)-6 and tumor necrosis factor alpha (TNF-α).
1 Pro-inflammatory cytokines have been suggested to explain the association between prenatal infection and children's risk of neuropsychiatric disorders because these cytokines can pass through the placenta and the blood-brain barrier and lead to aberrant neural growth and plasticity. 2 Inflammatory processes are among the factors that underlie abnormal brain development, cognitive impairments, and behavioural disturbances in extremely preterm children. 3 To the extent that early pathogenic immune processes are involved in the aetiology of developmental disabilities 1 as well as poor neuropsychological functioning in children born very preterm, 3 it is anticipated that other aspects of child development could also be impacted by immune system activation. Prospective studies among preterm infants that assessed immune markers (ie, before the emergence of behavioural and cognitive impairments) suggest that low-grade inflammation adversely impacts child brain development. 2 However, few studies examined this association in term infants. 4, 5 Moreover, we do not yet know which markers of immune activity are most important for brain development, nor whether higher or lower levels of immune markers are associated with better or worse developmental outcomes.
Several cytokines are involved in central nervous system signalling to produce neurochemical and neuro-immune alterations that might translate into behavioural and cognitive abnormalities in children. 6 These signals induce processes such as migration and activation of inflammatory cells, and other vascular responses, which could in turn increase peripheral levels of cytokines and acute phase reactants. Chemokines, for example, monocyte chemotactic protein-1 (MCP-1), may also play a role in brain development because of their neuromodulatory role, neuro-transmitter-like effects, and their involvement in regulation of neurogenesis and neuronal migration. 7 Both decreased and increased levels of circulatory growth factors such as platelet-derived growth factor-AA (PDGF-AA) and PDGF-BB are reported in children with developmental disabilities. 8, 9 This study examines the prospective association between immune markers as measured in newborn dried blood spots (NDBS) and failing screening for developmental skills in a large sample of US children drawn from the general population. Neonatal blood specimens obtained from archived NBDS offer a simple and cost effective source to assess various biomarkers. 10 Immune markers including cytokines, chemokines, and acute phase reactants in newborns may reflect the immune system activation during perinatal period and serve as a proxy for perinatal immune disruption in neonates.
| ME THODS

| Participants
We used data from the Upstate KIDS Study, a population-based birth cohort in upstate New York, 2008-2010. 11 Recruitment was based on birth certificate indication of infertility treatment and plurality. Infertility treatments included 2 broad categories: (i) assisted reproductive technology-specific treatment including in vitro fertilisation or intracytoplasmic sperm injection, and (ii) ovulation induction via oral or injectable medications with or without intrauterine insemination. All livebirths conceived with infertility treatment and all of multiple gestations were recruited. Singletons not conceived by infertility treatment were also recruited at a 3:1 ratio to those conceived by treatment, while frequency matching on region of birth.
There were 3905 mothers of singletons and 1084 mothers of twins who were enrolled in the study. Here, we included singletons and a randomly selected twin in each pair (n = 4989) and excluded triplets and quadruplets (n = 134) due to small number. Parents consented to the use of residual NDBS for 3038 (60%) infants at 8 months.
Characteristics between parents who consented and those who did not were similar.
12
The New York State Department of Health and the University of Albany Institutional Review Board (IRB) approved the study and served as the IRB designated by the National Institutes of Health. All participants provided written informed consent.
| Measurements
NDBS were collected as part of the Newborn Screening Programme 2-3 days after birth. As required by the Programme, the hospitals shipped the NDBS within the first 24 hours of collection to the State's were associated with lower odds of ASQ failure. The associations did not exist if correction for multiple comparisons was performed, except for PDGF-AA. Analyses with developmental service use revealed similar null findings.
Conclusions:
Immune marker concentrations in NDBS may not be associated with developmental delay in the general population. Newborn concentrations of growth factor PDGF-AA may be protective of developmental delay in childhood.
K E Y W O R D S
development, immune markers, longitudinal, neonates, population-based laboratory. NDBS were stored at 4°C and later retrieved for blood spot analyses. Punches of the residual spots were extracted and handled in a similar manner as previously described. 13 Briefly, blood spots were extracted overnight (18) (19) (20) We assayed 24 immune markers with possible neuro-modulatory roles. [14] [15] [16] [17] Table 1 .
Instrument reported values for markers below the limit of detection (including samples where the instrument could not detect the presence of the analyte) were used without censoring. 18 Batch effects in the marker values were removed using COMBAT, a statistical program commonly used to remove batch-to-batch measurement error.
At ages 4-6, 8, 12, 18, 24, 30 , and 36 months, mothers reported on their children's development using the age appropriate Ages & Stages Questionnaire© (ASQ) (postal survey). 19 The ASQ is a parentcompleted developmental screening instrument recommended for the early identification of developmental delays in 5 domains: fine motor, gross motor, communication, personal-social functioning, and problem-solving ability. 19 The ASQ applies images and extensive instructions to make it comprehensible for parents and encourages them to participate in activities with their children to obtain an accurate developmental assessment and then respond to questions about their children's development. We implemented the ASQ-2 nd edition up to 12 months, and the 3 rd edition from 18 months onwards. Each questionnaire item was scored as "yes" = 10 points, "sometimes" = 5 points, and "not yet" = 0 points. The scores were summed for each domain (0-60 points) and domain specific fails were defined if scores were 2 standard deviations below the mean for the child's age based on ASQ scores in the US norm sample. 19 Study personnel called parents to follow-up when the child failed any of the 5 domains or parental concern was noted. Trained specialists implemented an age-appropriate follow-up ASQ for the domain(s) that failed or discussed concerns. We defined age at fail 
| Statistical analyses
Missing values of immune markers were imputed using a full Markov
Chain Monte Carlo data imputation and 10 datasets were created (Table 1) . For imputations, all markers were transformed for normality using a Box-Cox transformation, then imputed conditional on the values of other markers. The immune marker values were backtransformed after imputations.
We used generalised linear mixed models with logit link function and unstructured covariance matrices to estimate the odds ratios (OR) and 95% confidence intervals (CI) of ASQ failure per standard deviation change in levels of the immune markers. All models included a child-level random intercept to account for repeated ASQ measures. We examined the normality of residuals and transformed the values of immune markers using logarithm or square roottransformation, where appropriate. If any association existed with overall ASQ fail, the association between that immune marker and ASQ domain specific fails were also tested. We tested a non-linearity in the association between immune markers and ASQ failure using restricted cubic splines. We also calculated an inflammation score by summing the concentrations of markers for an individual, with above median values for pro-inflammatory markers assigned 1 point and −1 point for anti-inflammatory markers (IL-1ra). Biomarkers with both pro and anti-inflammatory effects (eg, MCP-1) were assigned 1 point if their production was induced by pro-inflammatory markers. This method, which considers the action of markers, has been described as a summary measure of inflammatory markers in other epidemiologic studies to limit the number of statistical tests. 22, 23 The association between inflammatory scores and failing the ASQ was also examined using generalised linear mixed models. Similar analyses were run with the reported use of developmental services at ages 30 and/or 36 months as the outcome. Additionally, we used an alternative approach, in which, we selected the immune markers associated with children's ASQ fail (two-sided P < .2) and examined the association with any ASQ and domain specific fails while these immune markers were mutually adjusted in 1 model (in total, 10 immune markers).
We selected confounders a priori considering maternal lifestyle factors, inflammation, and children neurodevelopment, 24-26 using a Directed Acyclic Graph. Models were adjusted for a child's sex, and maternal age, education, race, pregnancy smoking and alcohol drinking, pre-pregnancy BMI, private insurance, parity, plurality, mode of delivery, gestational age, and birthweight. Infertility treatment was not associated with children's development after accounting for plurality; 21 however, models were also adjusted for infertility treatment to account for the design. Models included the discrete "time" variable indicating the wave of ASQ assessment.
Missing values of parity were imputed using multiple imputations through creating 10 datasets based on a Bernoulli distribution with probabilities dependent on their observed distributions by infertility treatment type. Other covariates had <1% missing and therefore simple imputation was used to replace missing values. We examined the interaction with plurality to determine if associations in twins and singletons differed. Testing for interaction with sex was grounded on evidence showing vulnerability of male fetus to maternal immune system activation. 27 We performed correction for multiple comparisons using False Discovery Rate. We used SAS version 9.3 for analyses (SAS Institute Inc., Cary, NC). (Table S1 ). The percentage of screen fail in 5 domains of ASQ varied between 2-4%, which is lower than the 5% in norm population. Among the 2092 children with available data on the use of services, mothers reported using developmental services for 370 children (18%). Correlations between markers were generally low (average r < .4).
In unadjusted analyses, we observed associations between several immune markers and children's failing developmental screening (Figure 1 ). Except for sVCAM-1 (OR per standard deviation 1.25, 95% CI 1.11, 1.40), higher levels of immune markers were associated with lower odds of failing any ASQ in unadjusted models. In markerspecific models adjusted for maternal and child factors, most associations were attenuated and became imprecise ( Figure 1 ). Higher levels of PDGF-AA, PAI-1, SDF-1, and MIP-1β were associated with lower odds of failing overall ASQ after full adjustment (Table 3) . (Table 4) . Tables S2 and S3 show the associations of covariates with 2 selected immune markers, CRP (results became null after adjustment) and PDGF-AA (results changed minimally after adjustment), to reflect the effect of adjustment for covariates.
In analyses of ASQ domain-specific fails (Table 3) 
| COMMENT
| Principal findings
We used residual NDBS to examine the prospective association of 24 immune markers with child development in a large populationbased sample. Neonates with higher levels of 4 immune markers, that is, PDGF-AA, PAI-1, SDF-1, and MIP-1β, were less likely to fail 
| Interpretation
In addition to their well-known role in immune system response, immune molecules are shown to signal the central nervous system and initiate crucial brain processes during brain development. 6 Several cytokines have receptors in the brain regions, for example, the hippocampus and amygdala. 28 Production and action of these proteins are tightly regulated in cascades and therefore, extremely high and low levels could be detrimental to the developing brain. Several studies have attempted to show the programming effect of immune system dysregulation on brain development by measuring immune markers during gestation. 4, 5 It is postulated that adverse pregnancy events with a substan- Brown et al 24 showed that higher levels of maternal CRP during first and early second trimester of pregnancy was associated with a diagnosis of ASD in children. In contrast, a similar study found that maternal CRP levels in mid-pregnancy were lower in mothers of ASD children compared with controls. 25 Koks et al 26 reported that the observed association between maternal CRP and children's autistic traits was largely explained by sociodemographic and maternal health-related factors. Our findings provide further support that confounding may explain the inconsistencies across studies on CRP and child development, even though previous studies analysed maternal specimens. In unadjusted associations, higher levels Observations counted from singletons (n = 2400) and 1 randomly selected twin of each pair (n = 638). a Numbers are mean (standard deviation) for continuous normally distributed variables (birthweight, maternal age, and pre-pregnancy body mass index), median (90% range) for continuous variables with skewed distribution (gestational age), and percentage for categorical variables.
TA B L E 2 (Continued)
F I G U R E 1 Immune markers in newborns and developmental delay through age 3 y (n =3038). Lines denote adjusted odds ratios (95%confience intervals). Models adjusted for a child's sex, maternal age, maternal educational levels, maternal race, maternal history of smoking in pregnancy and drinking alcohol, maternal pre-pregnancy body mass index, having private insurance, parity, history of infertility treatment, plurality, mode of delivery, gestational age, and birthweight. Odds ratios refer to the effect estimates per standard deviation change in levels of immune marker (in logarithmic scale or square-root). Developmental delay was defined if children had scores 2 standard deviations below the mean for their age through age 3 y based on the Ages and Stages Questionnaire scores of several neonatal markers were associated with smaller odds of failing developmental screening. Adjusted models with ASQ and developmental service use revealed that most of these associations were explained by confounding. We have previously shown that maternal BMI is associated with increased inflammation and separately, that maternal obesity is associated with higher odds of failing gross motor development. 29, 30 While studies on neonatal samples universally consider gestational age at birth as a con- We found that neonates with higher levels of PAI-1, PDGF-AA, SDF-1, and MIP-1β were less likely to fail a developmental screening. PDFG-AA is a protein crucial for the myelination process in the central nervous system because of its key signalling role for regulation of differentiation of oligodendrocyte. It is hypothesised that decreased levels of PDGF-AA underlie the neurodevelopmental sequels in children maple syrup urine disease. 8 This growth factor also decreases in the cerebral spinal fluid with the progression of multiple sclerosis. 33 Because of the complex biological relation between immune molecules and their pleiotropic effects and relation TA B L E 3 Immune markers in newborns and developmental delay through age 3 y (n = 3038) 
| Strength of the study
This study has several strengths including large sample size, repeated measurement of children's development, and assessment of more than 24 immune markers. Upstate KIDS prospectively collected data on various important confounders.
| Limitation of the data
However, we faced limitations. First, our analysis did not include important cytokines with neuro-inflammatory roles such as IL-6, IL-8, IL-17, or TNF-α. Also, we acknowledge that the ASQ is a screening rather than a diagnostic tool. Nevertheless, the ASQ is a validated instrument that has been shown to identify children between 0-5 years of age with developmental delay. 19 ASQ has adequate psychometric properties (75% sensitivity and 81% specificity) and modest agreement with other instruments, 34 which make it a reliable, cost-effective, and feasible method to capture children's developmental abilities in large population-based studies. Furthermore, our analysis with maternal reports of the use of early developmental services revealed similar results as the analysis with ASQ. Another limitation is that Upstate KIDS experienced loss to follow-up, which motivated the use of generalised linear mixed effects models that are robust to loss to follow-up under the missing at random assumption. Immune markers were measured in archived NDBS and degradation of these markers was possible. However, we did not expect the degradation to be associated with child development and to introduce bias. We did not perform a comparison of concentrations of immune markers in NDBS and serum or plasma. Nonetheless, NDBS provide a robust and convenient sample for immunoassay analysis of immune markers in whole blood, if stored at low temperature (4°C or less). 35 
| CON CLUS IONS
Concentrations of immune markers in newborns were not associated with developmental outcomes in early childhood, except that children with higher levels of neonatal PDGF-AA were less likely to fail a developmental screening. Null associations indicate that the measurement of immune markers in NDBS may not be a strong early indicator of developmental delay in children from the general population. Neonatal concentrations of growth factor PDGF-AA may be protective of developmental delay in childhood. 
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